Fundraising Fox

Liti

72 employees on LinkedIn · 16 known investors

Brazilian healthtech offering a subscription weight-loss and metabolic-health service combining a smart scale, app and online medical team.

Also known as Liti Saúde · LITI SAUDE LTDA.

Investors · 16

Also in the syndicate · 12

André BoffEclipseonJosé Auriemo NetoJosué de AlencarJulian NuñezLatitudMarcos SalamaNewtopiaNortePedro CarvalhoRicardo BecharaSebastian Mejia

Company profile

researched Aug 2026

Liti (LITI SAUDE LTDA., operating as Liti Saúde) is a Brazilian healthtech company that supports people through weight loss and metabolic-health improvement. Its subscription service pairs a connected smart scale and mobile app with a dedicated online medical team made up of a doctor, dietitian and behavioural scientist. The scale automatically transmits weight and body-composition indicators — body-fat percentage, muscle mass and visceral fat — to the user's care team, and the app stores the history of these measurements so patients and clinicians can track progress continuously.

The app communicates with Liti's electronic health record system, feeding user data into health-improvement strategies. Care protocols centre on iterative food recommendations informed by real-time scale and app data, alongside guidance on sleep, stress management, routine medical assessments and behavioural change. Subscribers also get access to a community, curated recipes and dining guidance, and services from other wellness providers. The company frames its clinical goal as reducing diseases associated with overweight and obesity rather than treating disease after onset. Liti has also launched a lower-cost second product that relies more heavily on technology and data feedback loops, and app releases have added a medication-discount benefit (Liti + EMS) letting users check discounted pharmacy prices in the app.

Founding story

Co-founder Fernando Vilela, an economist and former marketing and growth leader (CMO) at Rappi, sought medical help for exhaustion he suspected was burnout and consulted numerous specialists without resolution. He then met Dr Eduardo Rauen, a physician specialising in lifestyle medicine (described elsewhere as a nutriologist and sports doctor), who told him he needed to lose 55lbs (reported as 25 kg) for optimal health. Vilela followed Rauen's clinical protocol, lost the weight, and the doctor-patient relationship became a friendship and then a series of brainstorming sessions. Their shared conclusion — that lifestyle change is hard and the traditional healthcare system is built to treat pain and disease rather than to sustain constant engagement — led them to create Liti as a 'health co-pilot'.

Business model

Consumer subscription: customers pay for a bundled package comprising Liti's smart scale hardware, the mobile app and access to an online multidisciplinary medical team. A second, more affordable subscription tier uses greater automation and data feedback loops to deliver comparable engagement and clinical outcomes at lower cost. Alongside direct-to-consumer sales, Liti has commercial relationships with a premium health insurance provider, a large Brazilian pharmacy chain and a corporate paying client.

Recurring subscription revenue from consumers, supplemented by B2B/B2B2C arrangements with a health insurer and a corporate client; the company reported reaching $1M in annual revenue.

Traction

Liti launched its service in January 2022. It has reported reaching $1M in annual revenue, a 40% increase in daily app usage following device–EHR integration, a 40% increase in 12-month retention, a 98% recommendation score, 24% week-on-week lead-generation growth in a recent quarter and a 60% reduction in customer acquisition cost. The Liti Saúde Android app has surpassed 10,000 downloads.

Latest developments

Liti has added a pharmacy-discount benefit (Liti + EMS) to its app, letting users check discounted medication prices and instructions for using the benefit before visiting a pharmacy, alongside simplified access to the benefit and improvements to entering online consultations. The company has also released a more affordable second product and is experimenting with asynchronous video and voice-note formats for its online appointment model.

Full profile — market position, technology, go-to-market, geography, history

Market position

Positions itself as a consumer 'health co-pilot' in Latin America, which it describes as the world's third-largest private healthcare market with roughly 50% of healthcare spending paid out of pocket and about 70% of a 650-million population affected by overweight or obesity. It claims clinical results comparable to some medications, including GLP-1 therapies, at a lower price point.

Combines hardware (smart scale), software (app and EHR) and human clinical expertise in one subscription, using continuous real-time data rather than periodic appointments; emphasises a 'food as medicine' protocol and lifestyle medicine aimed at healthspan instead of episodic disease treatment. Reported outcomes include a 98% recommendation score and clinical results the company compares with GLP-1 medications.

Technology

An integrated hardware-software-clinician stack: a smart scale that automatically pushes weight and body-composition readings to the care team, a consumer mobile app for tracking indicators and attending online consultations, and an electronic health record system that continuously ingests app and device data to shape personalised protocols. Data analysis is used to generate personalised diagnoses and iterative dietary recommendations; the company is also testing asynchronous video and voice notes to replace the monthly appointment model with more frequent day-to-day guidance, and adding tooling to the EHR, onboarding and training funnel.

Go-to-market

Community-led growth driven primarily by influencers and referrals from existing users, plus recommendations from doctors. Distribution is extended through a partnership with a premium health insurance provider, a collaboration with a major Brazilian pharmacy chain, and a Brazilian technology and agribusiness company as a paying corporate client. The company reports lead generation expanding 24% week-on-week in one recent quarter while cutting customer acquisition cost by 60%.

Men and women aged roughly 30–40 in Brazil who struggle with weight and recognise the links between food, weight and overall health; the company also serves users reached through an insurer, a pharmacy chain and a corporate client.

Geography

Headquartered in São Paulo, Brazil (Av. dos Tajuras 356, Sala 4, Cidade Jardim), serving the Brazilian market, with stated ambitions across Latin America.

History

The company was co-founded by Eduardo Rauen and Fernando Vilela, reported in November 2022 as having been founded a year earlier, and launched its service in January 2022. monashees led a pre-seed round, and Canary subsequently led a seed round of approximately $4 million (R$21 million) announced in November 2022, to fund expansion and product and technology development. The team was built with hires from Latin American technology companies including 99, Uber, Kavak, Gympass, Nubank and Stone. Liti later introduced a second, lower-cost product and added a medication-discount benefit with EMS inside its app.

Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Annual revenueJan 2023$1M
Google Play app downloadsAug 202610K+
Increase in 12-month retentionJan 202340%
Increase in daily app usageJan 202340%
Recommendation scoreJan 202398%
Reduction in customer acquisition costJan 202360%
Seed round amount (local currency)Nov 202221,000,000 BRL
Week-on-week lead generation growthJan 202324%

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 5

launches, deals, and filings
Aug 2026
Liti + EMS medication discount benefit in app

App release notes describe a Liti + EMS benefit allowing users to check discounted medication prices and instructions before going to the pharmacy.

source ↗

Jan 2023
Distribution partnerships with insurer, pharmacy chain and corporate client

Liti entered a partnership with a premium health insurance provider, collaborated with a major Brazilian pharmacy chain, and secured a Brazilian technology and agribusiness company as a paying client.

source ↗

Jan 2023
Launch of lower-cost second product

Liti introduced a second, more cost-effective version of its offering that relies more heavily on technology and data feedback loops while aiming to preserve engagement and clinical outcomes.

source ↗

Nov 2022
Liti raises ~$4M seed round led by Canary

Liti announced a seed round of $4 million (reported as R$21 million / $3.9 million), with participation from monashees, Canary, Grão, Norte, Eclipseon, Newtopia, The Fund and Latitud plus angel investors from Rappi, Inventa, Loopi Pay, Yuno Payments, Cayena, Salú, JHSF and Coteminas. Proceeds were earmarked for expansion and product and technology development.

$4M source ↗

Jan 2022
Liti service launch

Liti launched its online weight-loss and metabolic-health service.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 7

primary sources listed

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Liti do?
Brazilian healthtech offering a subscription weight-loss and metabolic-health service combining a smart scale, app and online medical team.
Who are Liti's investors?
Liti's investors include MONASHEES, Newtopia VC, Norte Ventures, Latitud Ventures.